NCT03285997View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

PHASE3UnknownINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

August 31, 2018

Conditions
Influenza Vaccine
Interventions
BIOLOGICAL

GC3110A

A single 0.5mL dose intramuscular injection

BIOLOGICAL

GCFLU Pre-filled syringe inj.

A single 0.25mL dose intramuscular injection

Trial Locations (1)

Unknown

The Catholic Univ.of Korea Seoul St.Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY

NCT03285997 - A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age | Biotech Hunter | Biotech Hunter